Inactive Instrument

Infopia Co.,Ltd Stock Korea S.E.

036220

KR7036220002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
-	-

08/09/25	Sewon Co.,Ltd and Polaris AI Corp. completed the acquisition of 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae.	CI
21/07/25	Sewon Co.,Ltd and Polaris AI Corp. agreed to acquire 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae for KRW 50 billion.	CI

Osang HealthCare Co Ltd is a Korea-based company primarily engaged in research and development of in vitro diagnostic medical devices. The Company operates through three segments. The Biochemical Diagnostic segment mainly develops products such as personal blood sugar measurement devices, glycated hemoglobin measurement devices, cholesterol measurement devices, liver disease measurement devices, and U-healthcare devices. The Immunodiagnostic segment is mainly engaged in the development of immunodiagnostic devices and measurement sensors. The Molecular Diagnostic segment mainly engages in the development of molecular diagnostic devices and reagents.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

-40%: Exceptional extension

SEIZE THE OFFER!

Market Cap	87.95B 0 64.99M 56.72M 53.29M 48.72M 91.37M 6.21B 91.29M 639M 247M 3.17B 244M 239M 10.25B	P/E 2024	-13.6x	P/E 2025	52.5x
Enterprise Value	90.43B 0 66.83M 58.33M 54.8M 50.1M 93.96M 6.39B 93.87M 657M 254M 3.26B 251M 245M 10.54B	EV / Sales 2024	1.82x	EV / Sales 2025	1.29x
Free-Float	37.73%	Yield 2024	4.39%	Yield 2025	-

08/09/25	Sewon Co.,Ltd and Polaris AI Corp. completed the acquisition of 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae.	CI
21/07/25	Sewon Co.,Ltd and Polaris AI Corp. agreed to acquire 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae for KRW 50 billion.	CI
16/12/24	Osang Healthcare Co.,Ltd announces Annual dividend, payable on April 10, 2025	CI
23/09/24	Tranche Update on Osang Healthcare Co.,Ltd's Equity Buyback Plan announced on June 17, 2024.	CI
23/09/24	Tranche Update on Osang Healthcare Co.,Ltd's Equity Buyback Plan announced on June 17, 2024.	CI
17/09/24	Osang Healthcare Co.,Ltd's Equity Buyback announced on June 17, 2024, has expired with 315,680 shares, representing 2.27% for KRW 4,993.67 million.	CI
17/06/24	Osang Healthcare Co.,Ltd announces an Equity Buyback for 375,657 shares.	CI
17/06/24	Osang Healthcare Co.,Ltd authorizes a Buyback Plan.	CI
22/05/24	Allez Health, Inc. announced that it has received $60 million in funding from Osang Healthcare Co.,Ltd	CI
24/04/24	Zense-Life Inc announced that it has received $60 million in funding from Osang Healthcare Co.,Ltd and other investors	CI
28/03/24	Kryptos Biotechnologies, Inc. announced that it has received $10 million in funding from Osang Healthcare Co.,Ltd	CI
18/03/24	Kryptos Biotechnologies, Inc. announced that it expects to receive $27.095308 million in funding from Osang Healthcare Co.,Ltd	CI

Manager	Title	Age	Since
Cheol-Hun Kang CEO	Chief Executive Officer	65	-
Byung-Yeol Yoo CEO	Chief Executive Officer	58	-
Mi-Sook Park COO	Chief Operating Officer	52	-

Director	Title	Age	Since
Byung-Yeol Yoo BRD	Director/Board Member	58	-
Yeo-Min Yoon BRD	Director/Board Member	57	11/08/2020
Jong-Nam Ahn CHM	Chairman	67	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GUARDANT HEALTH, INC.	+1.89%	+5.55%	+199.51%	+578.51%	23.33B
10X GENOMICS, INC.	+2.02%	+15.10%	+518.87%	+92.56%	10.31B
BIOMÉRIEUX	+1.31%	+2.38%	-35.63%	-18.76%	9.76B
CARIS LIFE SCIENCES, INC.	+2.68%	+20.81%	-3.41%	-	8.66B
LANTHEUS HOLDINGS, INC.	-0.28%	-0.32%	+98.37%	+65.92%	6.55B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+0.86%	+1.92%	-27.31%	-20.73%	5.76B
DIASORIN S.P.A.	-2.31%	+3.09%	-3.15%	-12.72%	4.43B
ANDON HEALTH CO., LTD.	+0.89%	+8.70%	+66.62%	+72.10%	4B
AUTOBIO DIAGNOSTICS CO., LTD.	+7.53%	+10.21%	-13.10%	-24.70%	2.77B
Average	+1.62%	+6.53%	+88.97%	+91.52%	8.4B
Weighted average by Cap.	+1.57%	+6.17%	+136.69%	+220.41%

Infopia Co.,Ltd Stock Korea S.E.

Stocks

036220

KR7036220002

Medical Equipment, Supplies & Distribution

Valuation: Infopia Co.,Ltd

Latest news: Infopia Co.,Ltd

Managers and Directors: Infopia Co.,Ltd

Diagnostic & Testing Substances

Financials

Company Profile

	2024	2025
Net sales	80.49B 0 59.48M 51.91M 48.78M 44.59M 83.63M 5.68B 83.55M 585M 226M 2.9B 223M 218M 9.38B	129B 0 95.06M 82.97M 77.95M 71.26M 134M 9.08B 134M 934M 361M 4.63B 357M 349M 14.99B
Net income	-11.36B -0 -8.4M -7.33M -6.89M -6.3M -11.81M -802M -11.8M -82.54M -31.89M -409M -31.51M -30.83M -1.32B	3.11B 0 2.3M 2.01M 1.88M 1.72M 3.23M 220M 3.23M 22.58M 8.72M 112M 8.62M 8.43M 362M
Net Debt	-9.47B -0 -7M -6.11M -5.74M -5.25M -9.84M -669M -9.83M -68.79M -26.58M -341M -26.26M -25.7M -1.1B	2.49B 0 1.84M 1.6M 1.51M 1.38M 2.59M 176M 2.58M 18.07M 6.98M 89.61M 6.9M 6.75M 290M